Clinical practice guideline for the management of volatile substance use
The Office for Aboriginal and Torres Strait Islander Health (OATSIH) in the Department of Health and Ageing has commissioned the NHMRC to produce a systematically developed clinical practice guideline for the management of volatile substance use.
Scope
This guideline will assist health and medical staff to identify, assess and treat people suffering the effects of volatile substances, in metropolitan, rural and remote communities across Australia. The guideline is suitable for use by health professionals including medical practitioners, nurses, aboriginal health workers, alcohol and other drug workers and allied mental health workers. The guideline is applicable in primary health, emergency, mental health, alcohol and drug service settings.
Scope of Volatile Substance Use Guideline (PDF, 76KB)
Volatile Substance Use Guideline Factsheet (PDF, 293KB)
Guideline Release
NHMRC Council considered the final version of the Consensus-Based Clinical Practice Guideline for the Management of Volatile Substance Use in Australia, appendices and the quick reference guide on Friday 17 June 2011. Council recommended that the CEO issue the guideline, appendices and quick reference guide under section 7 (1) (a) of the National Health and Medical Research Council Act 1992. The NHMRC CEO approved the issue of this guideline on Monday 8 August 2011.
The guideline was formally launched by the Hon Mark Butler, Minister for Mental Health and Ageing, and and the Hon Warren Snowdon, Minister for Indigenous Health via a joint media release.
Guideline materials
- Consensus-Based Clinical Practice Guideline for the management of volatile substance use in Australia
- Consensus-Based Clinical Practice Guideline for the management of volatile substance use in Australia - Appendices
- Caring for people who sniff petrol or other volatile substances: A quick reference guide for health workers
A limited number of printed copies can be ordered by e-mailing health@nationalmailing.com.au or by phoning (02) 6269 1080.
Guideline development process
A multidisciplinary committee was responsible for developing the guideline recommendations. The guideline development process was undertaken in accordance with NHMRC guideline principles and will involve the review of existing evidence. Where evidence was lacking, expert opinion was used to develop consensus-based recommendations.
Volatile Substance Use Guideline Development Committee
|
Name |
Position |
Affiliation |
|---|---|---|
|
CHAIR |
Senior Research Fellow |
Centre for Aboriginal Medical and Dental Health, University of Western Australia |
|
Dr John Coleridge |
Emergency Physician and General Practitioner |
Alfred Hospital Emergency and Trauma Centre, |
|
Dr Sheree Cairney |
Cognitive Neuroscientist |
Menzies School of Health Research |
|
Dr Jennifer Delima |
Rural& Remote General Practitioner |
Alice Springs Hospital |
|
Ms Susie Low |
Chief Executive Officer |
Mt Theo Program, Warlpiri Youth Development Aboriginal Corporation |
|
Ms Coralie Ober |
Research Fellow |
Queensland Alcohol and Drug Research and Education Centre, University of Queensland |
|
Dr Robert Parker |
Director of Psychiatry |
Top End Mental Health Service |
|
Mr Tristan Ray |
Co-manager |
CAYLUS, Tangentyere Council |
|
Ms Angela Rizk |
Coordinator – Volatile Substance Program |
Western Australia Drug and Alcohol Office |
|
Ms Jan Robertson |
Senior Research Officer |
School of Public Health, Tropical Medicine and Rehabilitation Sciences, James Cook University |
|
Ms Elizabeth Stubbs |
Senior Case Manager (VSA) |
Tobacco, Alcohol and Other Drug Services, Department of Health and Families |
|
Mr Blair McFarland |
Co-manager |
CAYLUS, Tangentyere Council |
|
Dr Sue Phillips |
Director, Research Implementation Program |
NHMRC (NICS) |
|
Ms Emma Lourey |
A/g Assistant Director, Research Implementation Program |
NHMRC (NICS) |
|
Mr Scott Crozier |
Consumer Representative |
Harm Reduction Victoria |
|
Ms Jenny Kelsall |
Consumer Advocate |
Harm Reduction Victoria |
Methodologist
Turning Point Alcohol and Drug Centre are the methodologists working on this guideline.
Contact details
For further information:
| vsu@nhmrc.gov.au | |
| phone: | (03) 8866 0400 |